style CD4 fill:#006494 style MS_Treatment fill:#1b5e20 style Neuro_Treatment fill:#1b5e20 style ALS_Diagnosis fill:#1b5e20 style MS fill:#ef5350 style ALS fill:#ef5350 style Neurodegeneration fill:#ef5350 style Inflammation fill:#ef5350 style Auto
...
CD46
Pathway Diagram
Mermaid diagram (expand to render)
Introduction
Cd46 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The CD46 gene encodes membrane cofactor protein (MCP), a crucial complement regulatory protein expressed on all nucleated cells. CD46 is a type I membrane protein that serves as a cofactor for factor I-mediated cleavage of C3b and C4b, protecting cells from complement-mediated damage [1].
CD46 is a member of the regulators of complement activation (RCA) gene family. The protein exists in multiple isoforms generated by alternative splicing, with different cytoplasmic tails that can signal differently. CD46 also serves as a receptor for several pathogens, including measles virus, adenovirus, and Streptococcus pyogenes [2].
Function
The CD46 protein functions as:
Complement Regulation: Serves as a cofactor for factor I cleavage of C3b and C4b, preventing complement activation on host cells
Host Cell Protection: Protects cells from complement-mediated lysis by regulating C3b deposition
Pathogen Receptor: Serves as a receptor for measles virus, adenovirus types 2 and 5, and Streptococcus pyogenes
Immune Modulation: Modulates T cell function and promotes regulatory T cell development
Signal Transduction: Can trigger intracellular signaling upon ligand binding
Disease Associations
Age-Related Macular Degeneration
CD46 variants are associated with AMD risk
CD46 plays a role in retinal pigment epithelial cell protection
Altered complement regulation contributes to drusen formation
Multiple Sclerosis
CD46 is implicated in MS pathogenesis
Regulates immune cell function and neuroinflammation
May influence disease progression and severity
Other Conditions
Atypical Hemolytic Uremic Syndrome: CD46 mutations can contribute to aHUS
Chronic Lymphocytic Leukemia: CD46 overexpression may promote immune evasion
Asthma: CD46 variants associated with disease severity
Epithelial cells: Strong expression on mucosal surfaces
Regulation
Cytokines can modulate CD46 expression
IFN-α and IFN-β upregulate CD46
Cell activation increases CD46 surface expression
Genetics
Located at 1q32.2 in the RCA gene cluster
Multiple isoforms generated by alternative splicing
Polymorphisms affect disease susceptibility
Clinical Significance
Therapeutic Target: CD46-targeted therapies in development for cancer and infections
Biomarker: CD46 expression levels may have diagnostic utility
Vaccine Vector: CD46 used as receptor for viral vaccine vectors
Background
The study of Cd46 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.